Curaleaf Holdings (CURLF) Liabilities from Discontinued Operations (2020 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Liabilities from Discontinued Operations of 7073000.0 in Q4 2025, down 20.57% quarter-over-quarter from 8905000.0 in Q4 2024, and down 20.57% on a YoY basis from 8905000.0 in Q4 2024.
Curaleaf Holdings (CURLF) Liabilities from Discontinued Operations (2020 - 2025) Analysis & Trends
Curaleaf Holdings' Liabilities from Discontinued Operations history runs 6 years deep, the most recent figure standing at 7073000.0 for Q4 2025.
- In Q4 2025, Liabilities from Discontinued Operations fell 20.57% year-over-year to 7073000.0; the TTM figure through Dec 2025 stood at 7073000.0 (down 20.57% YoY), while the FY2025 annual figure was 7073000.0, down 20.57% from the prior year.
- Liabilities from Discontinued Operations was 7073000.0 for Q4 2025 at Curaleaf Holdings, down from 8905000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 23045000000.0 in Q1 2022 to a low of 1067000.0 in Q3 2024.
- Historically, Liabilities from Discontinued Operations has averaged 1549350066.67 across 5 years, with a median of 12775000.0 in 2021.
- The sharpest annual moves came in 2022 and 2024: Liabilities from Discontinued Operations soared 180291.39% in 2022, then sank 95.67% in 2024.
- A 5-year view of Liabilities from Discontinued Operations shows it stood at 18581000.0 in 2021, then soared by 91.3% to 35545000.0 in 2022, then slumped by 74.19% to 9173000.0 in 2023, then retreated by 2.92% to 8905000.0 in 2024, then slipped by 20.57% to 7073000.0 in 2025.
- The last three Liabilities from Discontinued Operations figures came in at 7073000.0 (Q4 2025), 8905000.0 (Q4 2024), and 1067000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.07 Mn |
| Dec 31, 2025 | 7.07 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Dec 31, 2023 | 9.17 Mn |
| Dec 31, 2023 | 9.17 Mn |
| Sep 30, 2023 | 24.62 Mn |
| Sep 30, 2023 | 24.62 Mn |
| Jun 30, 2023 | 10.51 Mn |
| Jun 30, 2023 | 10.51 Mn |
| Dec 31, 2022 | 35.55 Mn |
| Dec 31, 2022 | 35.55 Mn |
| Sep 30, 2022 | 15.83 Mn |
| Sep 30, 2022 | 15.83 Mn |
| Jun 30, 2022 | 18.85 Mn |
| Jun 30, 2022 | 18.85 Mn |